Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Seth Klarman · Q1 2016

Baupost Group

Portfolio at the end of Q1 2016, from the 13F filed May 13, 2016. See the filing on EDGAR ↗

CompanyWeightValueSharesPriceHeld sinceChange
EMC EMC · history 20.0% $1.38B 51,851,500 $26.65 Q4 2015 Add 77%
Cheniere Energy LNG · history 14.6% $1.01B 29,841,174 $33.83 Q1 2014 Add 14%
Viasat VSAT · history 12.2% $847.5M 11,533,137 $73.48 Q2 2013 or earlier No change
Antero Resources AR · history 7.7% $534.9M 21,505,881 $24.87 Q3 2014 Add 12%
Allergan AGN · history 6.7% $461.4M 1,721,587 $268.03 Q1 2016 Buy
PBF Energy PBF · history 5.1% $353.3M 10,641,175 $33.20 Q3 2013 Reduce 3%
PayPal PYPL · history 3.9% $272.5M 7,059,745 $38.60 Q3 2015 Reduce 36%
Innoviva INVA · history 3.6% $249.5M 19,815,983 $12.59 Q2 2013 or earlier No change
Twenty-First Century Fox FOXA · history 3.1% $214.6M 7,696,922 $27.88 Q3 2015 Add 88%
Twenty-First Century Fox FOX · history 3.0% $205.2M 7,278,100 $28.20 Q3 2015 Add 11%
Olin OLN · history 2.7% $186.5M 10,739,202 $17.37 Q3 2015 Add 53%
Theravance Biopharma TBPH · history 1.8% $122.2M 6,500,991 $18.80 Q2 2014 Add 1%
Keryx Biopharmaceuticals KERX · history 1.7% $120.4M 25,791,678 $4.67 Q1 2014 No change
VMware VMW · history 1.7% $117.8M 2,252,694 $52.31 Q1 2016 Buy
Veritiv VRTV · history 1.6% $113.4M 3,044,385 $37.26 Q3 2014 Add 5%
Atara Biotherapeutics ATRA · history 1.5% $102.0M 5,359,632 $19.03 Q4 2014 No change
Forward Pharma FWP · history 1.3% $91.2M 5,367,300 $17.00 Q4 2014 No change
Novagold Resources NG · history 1.1% $75.6M 15,000,000 $5.04 Q2 2013 or earlier Reduce 21%
ChipMOS IMOS · history 0.9% $65.2M 3,751,853 $17.38 Q2 2013 or earlier No change
KLX KLXI · history 0.9% $64.3M 2,000,000 $32.14 Q1 2015 No change
SunEdison Semiconductor SEMI · history 0.8% $54.3M 8,372,979 $6.48 Q2 2014 No change
American International Group AIG.WS · warrants · history 0.6% $39.7M 2,124,551 $18.70 Q2 2013 or earlier Add 69%
Silver Run Acquisition SRAQ.U · units · history 0.6% $38.8M 3,750,000 $10.35 Q1 2016 Buy
Innoviva INVA.CV · convertible notes · history 0.5% $37.8M 48,230,000 prn Q3 2014 No change
Biotie Therapies BITI · history 0.5% $36.8M 1,395,000 $26.39 Q2 2015 No change
Paratek Pharmaceuticals PRTK · history 0.3% $23.4M 1,544,498 $15.17 Q4 2014 No change
Chesapeake Energy CHK.CV · convertible notes · history 0.3% $22.0M 34,800,000 prn Q1 2016 Buy
Sunrun RUN · history 0.3% $18.5M 2,848,082 $6.48 Q3 2015 No change
La Quinta LQ · history 0.2% $13.9M 1,111,000 $12.50 Q1 2016 Buy
Orexigen Therapeutics OREX · history 0.2% $12.5M 22,268,399 $0.56 Q3 2015 Add 882%
Kindred Biosciences KIN · history 0.2% $10.4M 3,013,848 $3.45 Q4 2013 No change
Citigroup C.WS · warrants · history 0.1% $10.3M 102,553,207 $0.10 Q2 2013 or earlier No change
Bellatrix Exploration BXE · history 0.1% $8.7M 8,653,281 $1.01 Q4 2014 Reduce 64%
Genworth Financial GNW · history 0.1% $4.6M 1,699,195 $2.73 Q1 2016 Buy
Trilogy Metals TMQ · history 0.1% $4.0M 10,600,758 $0.38 Q2 2013 or earlier No change
35 positions100.0%$6.92B

Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q4 2015, adjusted for stock splits.

Sector weighting

Sector weights in this 13F
Energy27.8%
Technology23.4%
Health care18.3%
Media & telecom18.3%
Financials & real estate5.3%
Materials3.8%
Industrials2.8%
Consumer discretionary0.2%

What changed from Q4 2015

← Q4 2015 Q2 2016 →